Clinical Trial Update: A Study to Evaluate the Tolerability, Safety and Efficacy of VGM-R02b [Phase 1]

View source ↗

Summary

This clinical trial update indicates that a Phase 1 study of VGM-R02b for Glutaric Acidemia Type I is currently recruiting to assess tolerability, safety, and p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glutaric Acidemia Type

Drugs mentioned

• VGM-R02b

Snippet

Sponsor: Shanghai Vitalgen BioPharma Co., Ltd. | Conditions: Glutaric Acidemia Type I, Glutaric Aciduria Type I | Phase 1 | Status: RECRUITING